Overexpression of SCARA3 caused a decrease in the Epithelial-Mesenchymal Transition (EMT) ability of lung cancer and an increase in sensitivity to cisplatin through AKT and JNK pathways. The gene discussed is SCARA3; the disease is lung cancer.